Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06166303

Number of Previous Cesarean Sections on the Results of Angiogenic Factors.

Hypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in developing countries. The only cure for THE is termination of pregnancy, which ends up being a decision in which gestational age and maternal risks must be balanced. Angiogenic factors have come to occupy an indispensable place in the arsenal of tools that can be used to separate the patient with a high likelihood of complications from those in whom prolongation of pregnancy could represent an important neonatal benefit.

Although the usefulness of angiogenic factors in these scenarios is known, little is known about the effects that other conditions might have on their serum levels, mainly those that have an effect on trophoblastic invasion, the process that initiates implantation of the pregnancy in the endometrium. The purpose of the present study is to assess the effect that a history of uterine surgery, such as caesarean section, might have on angiogenic factor scores in subjects with no history of a hypertensive disorder of pregnancy.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Saint Thomas H

Panama City, Provincia de Panamá, Panama

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 36 weeks of gestation or more
  • Singleton pregnancy
  • Previous cesarean section (case)

Exclusion criteria

  • Vasculitis
  • Twin pregnancy
  • Chronic endometritis
  • Smoking
  • Lupus
  • Renal failure
  • Liver disease
  • Thrombocytopenia

Treatment and study plan

sFlt-1/PGIF

Diagnostic Test

Index of sFlt-1/PGIF

Primary outcomes

  1. Index sFlt-1/PIGF

    Time frame: From the moment of randomization up until delivery. Between 24-48 hours.

    Angiogenic factors, normal value.

Secondary outcomes

  1. Progression to preeclampsia

    Time frame: Up until discharge. On average, 7 days

    Number of subjects that develop a preeclampsia

Study contacts

Contact information is provided by the study sponsor or research team.

Osvaldo Reyes, MD

CONTACT

[email protected]

+507 65655041

Sponsors and collaborators

Lead sponsor

Saint Thomas Hospital, Panama

Other

Registry information

Official study title

Effect of Number of Previous Cesarean Sections on the Results of Angiogenic Factors. A Descriptive, Prospective Study.

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 12, 2023
Registry last updated
Aug 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.